Bg pattern

ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information: Summary of Product Characteristics

Esomeprazol Mabo-Farma 40 mg Gastro-Resistant Tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Esomeprazol Mabo-Farma and what is it used for
  2. What you need to know before you take Esomeprazol Mabo-Farma
  3. How to take Esomeprazol Mabo-Farma
  4. Possible side effects
  5. Storage of Esomeprazol Mabo-Farma
  6. Contents of the pack and other information

1. What is Esomeprazol Mabo-Farma and what is it used for

Esomeprazol Mabo-Farma contains the active substance esomeprazole, which belongs to a group of medicines called ‘proton pump inhibitors’. These work by reducing the amount of acid produced by the stomach.

Esomeprazole is used for the treatment of the following conditions:

Adults

  • Gastro-oesophageal reflux disease (GORD). This is where acid from the stomach escapes into the gullet (the tube which carries food from the mouth to the stomach) causing pain, inflammation and heartburn.
  • Excessive acid production in the stomach caused by a tumour in the pancreas (Zollinger-Ellison syndrome).
  • Prevention of relapse of peptic ulcer disease in patients with a history of peptic ulcer disease treated with esomeprazol intravenously.

Adolescents from 12 years of age

  • Gastro-oesophageal reflux disease (GORD). This is where acid from the stomach escapes into the gullet (the tube which carries food from the mouth to the stomach) causing pain, inflammation and heartburn.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Esomeprazol Mabo-Farma

Do not take Esomeprazol Mabo-Farma

  • If you are allergic to esomeprazole or any of the other ingredients of this medicine (listed in section 6).
  • If you are allergic to other proton pump inhibitors (e.g. pantoprazole, lansoprazole, rabeprazole, omeprazole).
  • If you are taking a medicine that contains nelfinavir (used to treat HIV infection).
  • If you have ever had a skin reaction after treatment with a medicine similar to esomeprazole that reduces stomach acid.

If any of these conditions apply to you, do not take esomeprazole. If you are not sure, consult your doctor or pharmacist before taking esomeprazole.

Warnings and precautions

Consult your doctor or pharmacist before taking esomeprazole

  • If you have severe liver problems.
  • If you have severe kidney problems.
  • If you have ever had a skin reaction after treatment with a medicine similar to esomeprazole that reduces stomach acid.
  • If you are due to have a specific blood test (Chromogranin A).

Esomeprazole may mask the symptoms of other diseases. Therefore, if you notice any of the following before or while taking esomeprazole, contact your doctor immediately:

  • You lose a lot of weight without reason and have problems swallowing.
  • You have stomach pain or indigestion.
  • You start vomiting food or blood.
  • Your stools are black (blood-stained).

If your doctor has prescribed esomeprazole for you only when you have symptoms, you must contact your doctor if your symptoms persist or change.

Taking a proton pump inhibitor like esomeprazole, especially over a period of more than one year, may slightly increase the risk of hip, wrist, or spine fracture. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).

If you get a rash on your skin, especially in areas exposed to the sun, you should contact your doctor as soon as possible, as you may need to stop taking esomeprazole. Also, remember to mention any other symptoms that you may notice, such as joint pain.

Severe skin reactions have occurred in patients taking esomeprazole (see also section 4). The rash may include ulcers in the mouth, throat, nose, genitals, and conjunctivitis (red and swollen eyes). These severe skin reactions usually occur after symptoms similar to flu, such as fever, headache, and body aches. The rash may cover large areas of the body with blisters and peeling skin.

If at any time during treatment (even after several weeks) you develop a rash or any of these skin symptoms, stop taking this medicine and contact your doctor immediately.

Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in relation to esomeprazole treatment. Stop taking esomeprazole and seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.

Children under 12 years of age

Information on dosing for children from 1 to 11 years is presented in the esomeprazole product information for sachets (consult your doctor or pharmacist if you need additional information).

Other medicines and Esomeprazol Mabo-Farma

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes medicines obtained without a prescription. This is because esomeprazole may affect how these medicines work and these medicines may affect how esomeprazole works.

Do not take esomeprazol tablets if you are taking a medicine that contains nelfinavir(used to treat HIV infection).

Tell your doctor if you are using any of the following medicines:

  • Atazanavir (used to treat HIV infection).
  • Clopidogrel (used to prevent blood clots).
  • Ketoconazole, itraconazole, or voriconazole (for fungal infections).
  • Erlotinib (used to treat cancer).
  • Citalopram, imipramine, clomipramine (for depression).
  • Diazepam (used to treat anxiety, as a muscle relaxant, or for epilepsy).
  • Phenytoin (for epilepsy). If you are taking phenytoin, your doctor will need to monitor you when you start or stop taking esomeprazole.
  • Medicines used to make the blood thinner, such as warfarin. Your doctor may need to monitor you when you start or stop taking esomeprazole.
  • Cilostazol (used to treat intermittent claudication – leg pain when walking caused by poor blood circulation).
  • Cisapride (used for indigestion and heartburn).
  • Digoxin (used for heart problems).
  • Methotrexate (a chemotherapy medicine used at high doses in cancer treatment) – if you are taking high doses of methotrexate, your doctor may temporarily stop your esomeprazole treatment.
  • Tacrolimus (organ transplant).
  • Rifampicin (used to treat tuberculosis).
  • St. John's Wort (Hypericum perforatum) (used to treat depression).

If your doctor has prescribed the antibiotics amoxicillin and clarithromycin in addition to esomeprazole to treat ulcers caused by Helicobacter pylori, it is very important that you inform your doctor if you are taking any other medicine.

Taking Esomeprazol Mabo-Farma with food and drinks

You can take the tablets with or without food.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will decide whether you can take esomeprazole during this time.

It is not known if esomeprazole passes into breast milk. Therefore, you should not take esomeprazole during breast-feeding.

Driving and using machines

Esomeprazole is unlikely to affect your ability to drive or use any tools or machines. However, side effects such as dizziness or blurred vision (see section 4) may occur. Do not drive or use any tools or machines if you notice any of these effects.

Esomeprazol Mabo-Farma contains sucrose

Esomeprazol contains sugar spheres that contain sucrose, a type of sugar. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.

Esomeprazol Mabo-Farma contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per gastro-resistant tablet; this is essentially ‘sodium-free’.

3. How to take Esomeprazol Mabo-Farma

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • If you take this medicine for a long time, your doctor will need to keep checking you (especially if you take it for more than one year).
  • If your doctor has told you to take this medicine only when you have symptoms, tell your doctor if your symptoms change.

How much to take

  • Your doctor will have told you how many tablets to take and when to take them. This will depend on your condition, age, and liver function.
  • The recommended doses are as follows:

Use in adults aged 18 years and above

For the treatment of heartburn caused by gastro-oesophageal reflux disease (GORD):

  • If your doctor has found that your oesophagus is slightly damaged, the recommended dose is one 40 mg gastro-resistant tablet of esomeprazole once a day for 4 weeks. Your doctor may tell you to take the same dose for another 4 weeks if your oesophagus has not yet healed.
  • If you have severe liver problems, your doctor may prescribe a lower dose.

For the treatment of excessive acid production in the stomach caused by a tumour in the pancreas (Zollinger-Ellison syndrome):

  • The recommended dose is 40 mg of esomeprazole twice a day.
  • Your doctor will adjust the dose according to your needs and will also decide how long you should take this medicine. The maximum dose is 80 mg twice a day.

Prevention of relapse of peptic ulcer disease in patients with a history of peptic ulcer disease treated with esomeprazol intravenously:

  • The recommended dose is one 40 mg tablet of esomeprazole once a day for 4 weeks.

Use in adolescents aged 12 years and above

For the treatment of heartburn caused by gastro-oesophageal reflux disease (GORD):

  • If your doctor has found that your oesophagus is slightly damaged, the recommended dose is one 40 mg gastro-resistant tablet of esomeprazole once a day for 4 weeks. Your doctor may tell you to take the same dose for another 4 weeks if your oesophagus has not yet healed.
  • If you have severe liver problems, your doctor may prescribe a lower dose.

Taking this medicine

  • You can take the tablets at any time of the day.
  • You can take the tablets with or without food.
  • Swallow the tablets whole with a glass of water. Do not chew or crush the tablets. This is because the tablets contain coated granules that prevent the medicine from being destroyed by the acid in the stomach. It is important not to damage the granules.

What to do if you have difficulty swallowing

  • If you have difficulty swallowing the tablets:
  • Put the tablets in a glass of water. Do not use other liquids.
  • Stir until the tablets break up (the solution will not be clear). You can drink the mixture straight away or within 30 minutes. Always stir well before drinking.
  • To make sure you take all the medicine, rinse the glass well with half a glass of water and drink. The solid particles contain the medicine – do not chew or crush the granules.
  • If you cannot swallow at all, the tablets can be dispersed in water and given through a syringe. The mixture can then be administered directly into the stomach through a tube (gastric tube).

Use in children under 12 years of age

Esomeprazole gastro-resistant tablets are not recommended for children under 12 years of age. Information on dosing for children from 1 to 11 years is presented in the esomeprazole product information for sachets (consult your doctor or pharmacist if you need additional information).

Elderly patients

No dose adjustment is necessary in elderly patients.

If you take more Esomeprazol Mabo-Farma than you should

If you take more esomeprazole than your doctor has recommended, contact your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, contact the Toxicology Information Service. Telephone 91 5620420, stating the medicine and the amount taken.

If you forget to take Esomeprazol Mabo-Farma

  • If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, do not take the missed dose.
  • Do not take a double dose (two doses at the same time) to make up for the missed dose.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

If you notice any of the following serious adverse effects, stop taking esomeprazol and contact a doctor immediately:

  • A sudden difficulty breathing, swelling of lips, tongue, and throat or body in general, skin rash, fainting, or difficulty swallowing (severe allergic reaction).
  • Redness of the skin with blisters or peeling. Large blisters and bleeding of the lips, eyes, mouth, nose, and genitals may also appear. This could be a "Stevens-Johnson Syndrome" or "toxic epidermal necrolysis".
  • Yellow skin, dark urine, and fatigue that can be symptoms of liver problems.
  • Widespread rash, high body temperature, and enlargement of lymph nodes (DRESS syndrome or drug hypersensitivity syndrome), which is very rare.

These effects are rare and may affect up to 1 in 1,000 people.

Other adverse effects include:

Frequent (may affect up to 1 in 10 people)

  • Headache.
  • Effects on the stomach or intestine: stomach pain, constipation, diarrhea, gas (flatulence).
  • Nausea or vomiting.
  • Benign polyps in the stomach.

Infrequent (may affect up to 1 in 100 people)

  • Swelling of feet and ankles.
  • Sleep disturbance (insomnia).
  • Dizziness, tingling, and numbness, drowsiness.
  • Feeling of vertigo.
  • Dry mouth.
  • Alteration of blood tests that determine liver function.
  • Skin rash, hives, itching of the skin.
  • Fracture of the hip, wrist, or spine (if esomeprazol is used at high doses and for a long period).
Rare (may affect up to 1 in 1,000 people)
  • Blood disorders such as a decrease in the number of white blood cells or platelets. This can cause weakness, bruising, or increase the likelihood of infections.
  • Low sodium levels in the blood. This can cause weakness, vomiting, and cramps.
  • Agitation, confusion, or depression.
  • Alteration of taste.
  • Eye disorders such as blurred vision.
  • Sudden feeling of shortness of breath or difficulty breathing (bronchospasm).
  • Inflammation inside the mouth.
  • An infection known as "candidiasis" that can affect the esophagus and is caused by a fungus.
  • Liver problems including jaundice that can cause yellow skin, dark urine, and fatigue.
  • Hair loss (alopecia).
  • Dermatitis due to sun exposure.
  • Pain in the joints (arthralgia) or muscle pain (myalgia).
  • General feeling of discomfort and lack of energy.
  • Increased sweating.

Very rare (may affect up to 1 in 10,000 people)

  • Changes in the number of cells in the blood, including agranulocytosis (decrease in the number of white blood cells).
  • Aggressiveness.
  • Seeing, feeling, or hearing things that do not exist (hallucinations).
  • Liver disorders that can lead to liver failure or brain inflammation.
  • Sudden appearance of severe skin rash, blisters, or peeling of the skin. These symptoms can be accompanied by high fever and joint pain. (Erythema multiforme, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis).
  • Muscle weakness.
  • Severe kidney disorders.
  • Enlargement of the breasts in men.

Frequency not known (frequency cannot be estimated from available data)

  • If you are being treated with esomeprazol for more than three months, your magnesium levels in the blood may decrease. Low magnesium levels can manifest as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, or increased heart rate. If you have any of these symptoms, inform your doctor immediately. Low magnesium levels can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform periodic tests to monitor your magnesium levels.
  • Inflammation of the intestine (can lead to diarrhea).
  • Skin rash, possibly with joint pain.

In very rare cases, esomeprazol can affect white blood cells, causing an immune deficiency. If you have an infection with symptoms such as fever with a severe worsening of your general condition or fever with symptoms of a local infection such as pain in the neck, throat, mouth, or difficulty urinating, you should consult your doctor as soon as possible to rule out a decrease in the number of white blood cells (agranulocytosis) through a blood test. It is important that, in this case, you inform your doctor about your medication.

Reporting of Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Esomeprazol Mabo-Farma

  • Keep this medicine out of the sight and reach of children.
  • Do not store at a temperature above 30°C.
  • Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Esomeprazol Mabo-Farma

  • The active ingredient is esomeprazol. Each gastro-resistant tablet contains 40 mg of esomeprazol (as esomeprazol magnesium dihydrate).
  • The other components are:

Tablet content: Copolymer of methacrylic acid and ethyl acrylate (1:1) dispersion 30% (methacrylic acid, ethyl acrylate, polysorbate 80, and sodium lauryl sulfate), talc, triethyl citrate, hypromellose, sugar spheres (sucrose and cornstarch), magnesium stearate, hydroxypropyl cellulose, glycerol, mono-stearate 40-55, polysorbate 80, microcrystalline cellulose, povidone, macrogol, crospovidone, sodium stearyl fumarate.

Tablet coating: Hypromellose, titanium dioxide (E171), macrogol, red iron oxide (E172), yellow iron oxide (E172).

Appearance of the Product and Package Contents

  • Esomeprazol Mabo-Farma 40 mg gastro-resistant tablets are film-coated, biconvex, elliptical, pink, 8.2 x 17 mm.
  • The tablets are presented in

Bottles of 28 and 56 tablets.

Blister packs in boxes and/or cartons of 28 and 56 tablets.

  • Some package sizes may only be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

MABO-FARMA, S.A.

Calle Vía de los Poblados, 3, Edificio 6

28033 Madrid,

Spain

Manufacturer:

BALKANPHARMA DUPNITSA AD

3 Samokovsko Shosse Str.

Dupnitsa 2600- Bulgaria.

Date of the Last Revision of this Prospectus: February 2025

Other Sources of Information

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

_____________________________________________________________________________

This information is intended only for healthcare professionals:

Administration through a gastric tube

  1. Insert the tablet into a suitable syringe and fill the syringe with approximately 25 ml of water and approximately 5 ml of air. For some tubes, a dispersion in 50 ml of water is required to avoid clogging the tube.
  2. Shake the syringe immediately for approximately 2 minutes to disperse the tablet.
  3. Hold the syringe with the tip up and check that the tip is not clogged.
  4. Connect the syringe to the tube while maintaining the previous position.
  5. Shake the syringe and place it with the tip down. Inject immediately 5-10 ml into the tube. Invert the syringe after injection and shake (the syringe must be kept with the tip up to avoid clogging the tip).
  6. Put the syringe back with the tip down and inject immediately another 5-10 ml into the tube. Repeat this procedure until the syringe is empty.
  7. Fill the syringe with 25 ml of water and 5 ml of air and repeat step 5 if necessary to flush any remaining sediment from the syringe. For some tubes, 50 ml of water are required.

Online doctors for ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS

Discuss questions about ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS?
ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS?
The active ingredient in ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS is esomeprazole. This information helps identify medicines with the same composition but different brand names.
How much does ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS cost in pharmacies?
The average pharmacy price for ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS is around 25.1 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS?
ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS is manufactured by Mabo Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ESOMEPRAZOL MABO-FARMA 40 mg GASTRO-RESISTANT TABLETS?
Other medicines with the same active substance (esomeprazole) include AXIAGO 20 mg GASTRO-RESISTANT TABLETS, AXIAGO 40 mg GASTRO-RESISTANT TABLETS, EMANERA 20 mg GASTRO-RESISTANT HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media